Abstract
A new, single bolus method of in vivo blood pool imaging using a technetium Tc99m phosphine isocyanide complex (DEPIC) which binds to pre-albumin was evaluated in volunteers (n=4) and patients (n=20). DEPIC was assessed for its safety and possible drug interactions. Its duration of action and quality of ventriculography were compared with imaging using standard in vivo red cell labelling (PYP) during two 3-h scanning periods 1 week apart. DEPIC had a mean plasma halflife of 3.3 h. The count rate over the left ventricle was initially 42% higher with DEPIC than with PYP. However, removal of DEPIC by the liver resulted in equivalent count rates by 1 h, and by 3 h PYP count rates were 22% higher than DEPIC. Immediately post injection mean (SD) difference in the left ventricular ejection fraction between the two methods was 2.4% (7.7%). Satisfactory DEPIC scans were obtained up to 2 h post injection, but by 3 h there was a mean difference of 13% (11.3%). DEPIC was found to be a safe alternative to red all labelling for blood pool angiography, suitable for routine work. The single bolus methodology and high initial count rates offer improved efficiency and a capability for truly emergency scanning.
Similar content being viewed by others
References
Burow R, Strauss HW, Singleton R, et al. (1977) Analysis of left ventricular function from multiple gated acquisition (MUGA) cardiac blood pool imaging: comparison to contrast angiography. Circulation 56:1024–1028
Hains A, Al Khawaja I, Hinge DA, Lahiri A, Raftery EB (1987) Radionuclide left ventricular ejection fraction: a comparison of three methods. Br Heart J 57:242–246
Nemerouski M, Shah PK, Pichler M, et al. (1982) Radionuclide assessment of sequential changes in left and right ventricular function following first acute transmural myocardial infarction. Am Heart J 104:709–717
Pauwels EKJ, Feitsma RIJ, Blom J (1983) Influence of Adriamycin on red blood cell labelling, a pitfall in scintigraphic blood pool imaging. Nucl Med Comm 4:290–295
Pitt B, Strauss HW (1977) Current concepts: evaluation of ventricular function by radio-isotopes. N Engl J Med 296:1097–1099
Rhodes BA, Cordova MA (1979) Adverse reactions to radio-pharmaceuticals. Incidence in 1978, and associated symptoms. Report of the adverse reactions subcommittee of the Society of Nuclear Medicine. J Nucl Med 21:1107–1110
Smith T, Zanelli GD, Crawley JCW (1985) Acquisition of biolinetic data for internal dose calculations for some novel radiopharmaceuticals. 4th Int Radiopharmaceutical dosimetry symposium. CONF-8551113 Oak Ridge Associated Universities, pp 118–134
Strauss HW, Zaret BL, Hurley PJ, Naratajan TK, Pitt B (1971) A scintigraphic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol 28:575–580
Zanelli GD (1982) Effect of certain drugs used in the treatment of cardiovascular disease on the ‘in vitro’ labelling of red blood cells with 99mTc. Nucl Med Comm 3:155–161
Zanelli GD, Lahiri A, Petel N, et al. (1987) Annual and human studies of a new 99mTc labelled phosphine-isocyanide complex with possible applications to radionuclide ventriculography. Eur J Nucl Med 13:12–17
Zanelli GD, Cook N, Lahiri A, et al. (1988) Protein binding studies of technetium 99m labelled phosphine and isocyanide cationic complexes. J Nucl Med 29:62–67
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brigden, G., Zanelli, G., Lahiri, A. et al. Blood pool ventriculography with a new technetium-labelled complex (99mTc-DEPIC) : a clinical evaluation. Eur J Nucl Med 16, 795–799 (1990). https://doi.org/10.1007/BF00833013
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00833013